You have 3 free guides left 😟
Unlock your guides
You have 3 free guides left 😟
Unlock your guides

Genetic engineering and gene therapy offer exciting possibilities for treating diseases and improving lives. These technologies can correct faulty genes, potentially curing inherited disorders and reducing healthcare costs. However, they also raise ethical concerns about unintended consequences, accessibility, and the potential for human enhancement.

The benefits of gene-editing tools like must be weighed against risks like off-target effects. While somatic cell editing is less controversial, germline modifications that affect future generations spark intense debate. Balancing medical progress with ethical considerations is crucial as these technologies advance.

Ethical Implications of Genetic Engineering and Gene Therapy

Ethical implications of genetic engineering

Top images from around the web for Ethical implications of genetic engineering
Top images from around the web for Ethical implications of genetic engineering
  • Potential benefits
    • Treating genetic disorders and diseases by correcting faulty genes (cystic fibrosis, sickle cell anemia)
    • Improving quality of life for patients by alleviating symptoms and reducing disease burden
    • Reducing healthcare costs associated with chronic conditions by providing long-term solutions
  • Potential risks and concerns
    • Unintended consequences and side effects due to complex gene interactions and incomplete understanding of the genome
    • Accessibility and affordability of treatments may create disparities in healthcare access (high-cost gene therapies)
    • Ethical considerations surrounding human enhancement and the potential for creating "" with desired traits
  • and patient
    • Ensuring patients fully understand the risks and benefits through comprehensive genetic counseling and education
    • Protecting vulnerable populations from exploitation, such as those with limited decision-making capacity or socioeconomic disadvantages
  • Societal impact and public perception
    • Addressing concerns about "playing God" or altering natural processes, which may conflict with religious or cultural beliefs
    • Engaging in public discourse and education to foster understanding and address misconceptions about genetic engineering

Benefits vs risks of gene-editing technologies

  • CRISPR-Cas9 technology
    • Precise and efficient gene-editing tool that allows for targeted modifications to the genome (knock-out or knock-in of specific genes)
    • Potential for treating genetic disorders and diseases by correcting disease-causing mutations (Huntington's disease, muscular dystrophy)
    • Concerns about off-target effects and unintended mutations that may have deleterious effects on health or development
  • Somatic cell
    • Modifying non-reproductive cells to treat individual patients without passing changes to future generations
    • Less controversial than germline modifications as it focuses on treating existing individuals
    • Potential for personalized medicine and targeted therapies that address specific genetic profiles or disease subtypes (cancer immunotherapy)
  • Germline modifications
    • Editing reproductive cells or embryos, resulting in changes that are passed down to future generations
    • Potential for eliminating genetic disorders and diseases from the gene pool and reducing the burden of inherited conditions
    • Ethical concerns about altering the human genome and the long-term effects on the gene pool and future generations
  • Regulation and oversight
    • Ensuring responsible use and development of gene-editing technologies through robust regulatory frameworks and guidelines
    • Establishing guidelines and protocols for research and clinical applications to minimize risks and ensure ethical conduct

Ethical Challenges in Germline Modifications and Gene Therapy

Ethics of germline modifications

  • Germline modifications
    • Permanent changes to the human genome that are passed down to future generations, affecting the gene pool
    • Potential for eliminating genetic disorders and diseases by correcting mutations in reproductive cells or embryos
    • Concerns about unintended consequences and long-term effects on human evolution and genetic diversity
  • Designer babies and genetic enhancement
    • Selecting or modifying traits for non-medical reasons, such as intelligence, athleticism, or appearance
    • Ethical implications of creating "perfect" or "superior" individuals and the potential for exacerbating social inequalities
    • Potential for discrimination and stigmatization based on genetic profiles or enhanced capabilities
  • Slippery slope argument
    • Concern that allowing germline modifications for medical purposes could lead to more controversial applications, such as enhancement
    • Difficulty in drawing clear lines between medical necessity and enhancement, as the boundaries may shift over time
  • Intergenerational and consent
    • Modifying the genome of future generations without their explicit consent raises questions about their autonomy and rights
    • Balancing the rights and interests of current and future individuals in making decisions about germline modifications

Challenges of gene therapy applications

  • Gene therapy for inherited disorders
    • Treating genetic conditions by introducing functional genes to replace or compensate for faulty ones (severe combined immunodeficiency, hemophilia)
    • Potential for alleviating suffering and improving quality of life by addressing the root cause of the disorder
    • Challenges in ensuring safety, efficacy, and long-term outcomes, as gene therapies are still a relatively new and complex field
  • Gene therapy for enhancement purposes
    • Using gene therapy to enhance human capabilities or traits beyond what is considered normal or healthy
    • Ethical concerns about creating unfair advantages and social disparities, as enhanced individuals may have significant advantages in various domains
    • Distinguishing between medical necessity and elective enhancement, as the line between treatment and enhancement can be blurry
  • Access and distribution of gene therapies
    • Ensuring equitable access to treatments regardless of socioeconomic status, as high costs may limit availability to wealthy individuals or nations
    • Addressing potential for and stigmatization based on access to or use of gene therapies
  • Societal impact and public trust
    • Fostering public understanding and engagement in decision-making processes related to gene therapy research and applications
    • Maintaining transparency and accountability in research and clinical applications to build public trust and confidence in the technology
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Glossary
Glossary